Brennan Kevin M. 4
4 · Xilio Therapeutics, Inc. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Transactions
- Award
Stock Option (right to buy)
2024-10-01+26,000→ 26,000 totalExercise: $0.75Exp: 2034-09-30→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]The option was granted on October 1, 2024 and will vest as to 100% of the shares underlying the option on September 30, 2025, subject to the Reporting Person's continued service to the Issuer or its subsidiaries through the vesting date.